局部丹参酮IIA磺酸钠通过调控炎症、免疫与破骨信号减轻牙周骨丧失
在结扎诱导的小鼠牙周炎模型中,局部给予丹参酮IIA磺酸钠(STS)可减轻牙周骨丧失、保留骨微结构并减少炎症浸润。机制上STS抑制RANKL依赖的破骨生成、抑制NF-κB通路并减少M1样巨噬细胞极化,同时部分恢复成骨通路。
要点
- 局部STS减轻小鼠牙周炎骨丧失并保留骨微结构。
- STS抑制RANKL依赖的破骨生成并恢复RANKL/OPG平衡。
- STS抑制NF-κB通路并减少M1样巨噬细胞极化。
核心结论
- STS通过调控炎症信号、减弱M1样巨噬细胞极化、抑制破骨生成并部分恢复成骨通路,有效抑制牙周炎症和牙槽骨破坏。
研究设计与样本
- 在P、STS1和STS5组双侧上颌第一磨牙放置结扎线诱导实验性牙周炎,STS或溶剂在诱导前2天开始局部给予牙龈组织并持续至实验结束。
主要发现
- STS显著减轻牙周骨丧失、保留骨微结构、减少炎症浸润并维持胶原组织。
- STS通过下调RANKL、CTSK、MMP-9、OSCAR和NFATc1 mRNA表达并恢复RANKL/OPG平衡,抑制RANKL依赖的破骨生成。
- STS抑制NF-κB通路激活,表现为NF-κB蛋白水平降低、IκBα稳定以及IL-6、TNF-α和TGF-β基因表达受抑,IFN-γ基因水平呈下降趋势。
- STS减少M1样巨噬细胞(F4/80+CD80+信号降低)并增加CD206免疫反应性。
- 蛋白水平上STS降低TRAP、CTSK和NFATc1表达并恢复RUNX2。
临床怎么用
- 局部STS可能作为辅助手段用于抑制牙周炎症和牙槽骨破坏,但需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To investigate whether local administration of sodium tanshinone IIA sulfonate (STS) modulates periodontal inflammation, alveolar bone loss, immune response and bone remodelling-related signalling pathways in a ligature-induced murine model of periodontitis. MATERIALS AND METHODS: Sixty C57BL/6J male mice were randomly assigned to four groups: control group (C), periodontitis (P), low-dose (1 mg/kg) tanshinone (STS1) and high-dose (5 mg/kg) tanshinone treatment (STS5). Experimental periodontitis was induced by bilateral placement of ligatures around the first maxillary molars in the P, STS1 and STS5 groups. STS or vehicle was administered locally to the gingival tissues 2 days before disease induction and continued until the end of the experiment. RESULTS: STS significantly attenuated periodontal bone loss, preserved bone microarchitecture, reduced inflammatory infiltrate and maintained collagen organisation. Mechanistically, STS suppressed RANKL-dependent osteoclastogenesis by down-regulating RANKL, CTSK, MMP-9, OSCAR and NFATc1 mRNA expression while restoring the RANKL/OPG balance, thereby limiting osteoclast differentiation and activity. In parallel, STS attenuated inflammatory signalling by inhibiting NF-κB pathway activation, as reflected by reduced NF-κB protein levels, stabilisation of its inhibitory regulator IκBα as well as suppression of IL-6, TNF-α and TGF-β gene expression, followed by a trend towards reduced IFN-γ gene levels. STS further modulated macrophage polarisation by reducing M1-like macrophages, as shown by decreased F4/80+CD80+ signal, while CD206 immunoreactivity increased. At the protein level, STS reduced TRAP, CTSK and NFATc1 expression while restoring RUNX2. CONCLUSION: STS effectively suppresses periodontal inflammation and alveolar bone destruction by modulating inflammatory signalling and attenuating M1-like macrophage polarisation, inhibiting osteoclastogenesis and partially restoring osteogenic pathways.
引用
- de Molon RS, Scarel-Caminaga RM, Caldeira FID, et al. Local Sodium Tanshinone IIA Sulfonate Attenuates Periodontal Bone Loss by Modulating Inflammatory, Immune and Osteoclastogenic Signalling. J Clin Periodontol. 2026. PMID: 42400288. doi:10.1111/jcpe.70159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。